Established in Bethesda in 2019 as the first global subsidiary of a Japanese pharmaceutical company founded in Tokyo in 2003, Nobelpharma America develops and brings medicines and medical devices to U.S. patients with rare or underserved conditions. Its purpose is to pursue treatments that larger companies may overlook because few patients are affected or existing options are limited. The company works with worldwide experts to move essential therapies from development toward patients, caregivers, and health care providers.
NOF AMERICA CORPORATIONEstablished in 1988, NOF AMERICA CORPORATION is the American subsidiary of Japan’s NOF CORPORATION, serving customers across North and South America. It is known for helping research and development teams apply specialized materials to pharmaceutical and healthcare work, with regional offices in the United States.WHITE PLAINS, NY
Leadiant Biosciences, IncFrom its Rockville base, Leadiant Biosciences develops and distributes prescription therapies for people living with rare diseases. The private U.S. pharmaceutical company draws on a longstanding heritage in orphan-drug development, becoming the fourth company in the world to receive a U.S. Orphan Drug Designation in 1984. Its research teams work with physicians, researchers, academic institutions and biotechnology organizations, while patient-support programs provide education and resources beyond the medicine itself.ROCKVILLE, MD
Jubilant Cadista Pharmaceuticals IncJubilant Cadista Pharmaceuticals Inc. is a generic-pharmaceutical business built around dependable access to medicines for underserved markets. Serving the U.S. market from its corporate base in Pennsylvania and a manufacturing facility in Roorkee, India, the company supplies finished dosage products and supports customers from formulation development through distribution.325412YARDLEY, PA
Cipla USA, IncCipla USA, Inc. is the wholly owned US subsidiary of Cipla Limited, supplying patients with access to medicines and operating manufacturing units in New York and Massachusetts. Its US-market production includes tablets, capsules, and inhalation products; the company says its US journey began in 1984, when Cipla became the first Indian company to receive US FDA approval. Cipla Limited dates its origins to 1935 and describes a global pharmaceutical business with 47 manufacturing sites and a portfolio of more than 1,500 products.CENTRAL ISLIP, NY